Belimumab for systemic lupus erythematosus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Belimumab for Systemic Lupus Erythematosus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438479/all/Vortioxetine_for_depression_in_adults_New. Accessed 29 March 2024.
Belimumab for systemic lupus erythematosus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438479/all/Vortioxetine_for_depression_in_adults_New. Accessed March 29, 2024.
Belimumab for systemic lupus erythematosus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438479/all/Vortioxetine_for_depression_in_adults_New
Belimumab for Systemic Lupus Erythematosus [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438479/all/Vortioxetine_for_depression_in_adults_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Belimumab for systemic lupus erythematosus
ID - 438479
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438479/all/Vortioxetine_for_depression_in_adults_New
DB - Evidence Central
DP - Unbound Medicine
ER -